SPDR S&P Pharmaceuticals ETF
XPH
XPH
75 hedge funds and large institutions have $182M invested in SPDR S&P Pharmaceuticals ETF in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 28 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
43% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 21
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $234K
Holders
75
Holding in Top 10
1
Calls
–
Puts
$234K
Top Buyers
| 1 | +$25.1M | |
| 2 | +$18.1M | |
| 3 | +$10.5M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$8.37M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$3.56M |
Top Sellers
| 1 | -$3.95M | |
| 2 | -$3.22M | |
| 3 | -$2.16M | |
| 4 |
OLA
Oliver Luxxe Assets
Gladstone,
New Jersey
|
-$1.04M |
| 5 |
JPMPWA
J.P. Morgan Private Wealth Advisors
San Francisco,
California
|
-$1.02M |